Gümüş, T.;                     Özkılıç, A.;                     Temel, R.;                     Nart, D.;                     Yılmaz, F.;                     Karabulut, B.;                     Uğuz, A.    
        Perineural and Lymphovascular Invasion in Resected Pancreatic Ductal Adenocarcinoma: A High-Risk Subgroup That Could Benefit from Adjuvant Radiotherapy. J. Clin. Med. 2025, 14, 7763.
    https://doi.org/10.3390/jcm14217763
    AMA Style
    
                                Gümüş T,                                 Özkılıç A,                                 Temel R,                                 Nart D,                                 Yılmaz F,                                 Karabulut B,                                 Uğuz A.        
                Perineural and Lymphovascular Invasion in Resected Pancreatic Ductal Adenocarcinoma: A High-Risk Subgroup That Could Benefit from Adjuvant Radiotherapy. Journal of Clinical Medicine. 2025; 14(21):7763.
        https://doi.org/10.3390/jcm14217763
    
    Chicago/Turabian Style
    
                                Gümüş, Tufan,                                 Aykut Özkılıç,                                 Recep Temel,                                 Deniz Nart,                                 Funda Yılmaz,                                 Bülent Karabulut,                                 and Alper Uğuz.        
                2025. "Perineural and Lymphovascular Invasion in Resected Pancreatic Ductal Adenocarcinoma: A High-Risk Subgroup That Could Benefit from Adjuvant Radiotherapy" Journal of Clinical Medicine 14, no. 21: 7763.
        https://doi.org/10.3390/jcm14217763
    
    APA Style
    
                                Gümüş, T.,                                 Özkılıç, A.,                                 Temel, R.,                                 Nart, D.,                                 Yılmaz, F.,                                 Karabulut, B.,                                 & Uğuz, A.        
        
        (2025). Perineural and Lymphovascular Invasion in Resected Pancreatic Ductal Adenocarcinoma: A High-Risk Subgroup That Could Benefit from Adjuvant Radiotherapy. Journal of Clinical Medicine, 14(21), 7763.
        https://doi.org/10.3390/jcm14217763